Utah Medical Products, Inc. (NASDAQ: UTMD) - Quick read
Summary: UTMD delivered solid profitability and cash generation in 2Q/1H 2025 but saw revenue and gross‑profit pressure primarily from reduced OEM (PendoTECH) demand and weaker international sales. The company remains debt‑free with an activ...